《Journal Of Cystic Fibrosis》重点专注发布医学-呼吸系统领域的新研究,旨在促进和传播该领域相关的新技术和新知识。鼓励该领域研究者详细地发表他们的高质量实验研究和理论结果。根据网友分享的投稿经验,平均审稿速度为 较慢,6-12周 约6.1周。该杂志创刊至今,在医学-呼吸系统领域,影响力非凡,对来稿文章质量要求很高,稿件投稿过审难度很大,刊登文章的学术水平和编辑质量在同类杂志中均名列前茅。如果你想在该杂志上发表论文,你可以向编辑部提交文章,但文章必须具有重要意义并代表该领域专业的发展。我们欢迎广大同领域的研究者提交投稿。
CiteScore | SJR | SNIP | CiteScore排名 | |||
---|---|---|---|---|---|---|
10.1 | 2.043 | 1.341 | 学科类别 | 分区 | 排名 | 百分位 |
大类:大类:Medicine
小类:小类:Pediatrics,PerinatologyandChildHealth
|
Q1 | 13/330 | 96% | |||
大类:大类:Medicine
小类:小类:PulmonaryandRespiratoryMedicine
|
Q1 | 17/155 | 89% |
按JIF指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
---|---|---|---|---|
学科:RESPIRATORY SYSTEM | SCIE | Q1 | 15 / 100 | 85.5% |
按JCI指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
---|---|---|---|---|
学科:RESPIRATORY SYSTEM | SCIE | Q1 | 13 / 101 | 87.62% |
文章名称
引用次数
ECFS best practice guidelines: the 2018 revision
73
CFTR modulator theratyping: Current status, gaps and future directions
33
Up-to-date and projected estimates of survival for people with cystic fibrosis using baseline characteristics: A longitudinal study using UK patient registry data
30
Lung transplant referral for individuals with cystic fibrosis: Cystic Fibrosis Foundation consensus guidelines
22
Multicentre standardisation of chest MRI as radiation-free outcome measure of lung disease in young children with cystic fibrosis
17
Lumacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease homozygous for F508del-CFTR
17
Animal and model systems for studying cystic fibrosis
15
Isogenic cell models of cystic fibrosis-causing variants in natively expressing pulmonary epithelial cells
14
Epidemiology of CF: How registries can be used to advance our understanding of the CF population
13
Predictive factors for lumacaftor/ivacaftor clinical response
13
国家/地区
发文量
TUSA
240
TEngland
89
TAustralia
68
TCanada
61
TFrance
59
TNetherlands
50
TGERMANY (FED REP GER)
47
TItaly
46
TBelgium
36
TNORTHERN IRELAND
28





